PE/Cyanine7 anti-mouse CD31 Antibody

Pricing & Availability
Clone
390 (See other available formats)
Regulatory Status
RUO
Other Names
PECAM-1, EndoCAM
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
390_PECy7_011108
C57BL/6 mouse splenocytes stained with 390 PE/Cyanine7
  • 390_PECy7_011108
    C57BL/6 mouse splenocytes stained with 390 PE/Cyanine7
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
102417 25 µg 101 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
102418 100 µg 229 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD31 is a 130-140 kD glycoprotein, also known as platelet endothelial cell adhesion molecule (PECAM-1) and EndoCAM. It is a member of the Ig superfamily, expressed on endothelial cells, platelets, granulocytes, monocytes/macrophages, dendritic cells, and T and B cell subsets, and is critical for cell-cell interactions. The primary ligands for CD31 have been reported to be CD38 and the vitronectin receptor (αv β3 integrin, CD51/CD61). Other reported functions of CD31 are neutrophil emigration to sites of inflammation and angiogenesis.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C3H/HeJ mouse hematopoietic progenitor cell line 3
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Anti-mouse CD31 clones 390 and MEC13.3 bind to their respective non-overlapping epitopes in IgD2 of CD31.8 Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo blocking of CD31-mediated cell-cell interactions1-4, and immunohistochemical staining5,6,7 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections. Special Note: This antibody is not recommended for formalin-fixed paraffin-embedded sections. The LEAF™ purified antibody (Endotoxin < 0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 102412).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Baldwin HS, et al. 1994. Development 120:2539. (IP, Block)
  2. DeLisser HM, et al. 1997. Am. J. Pathol. 151:671. (Block)
  3. Rosenblum WI, et al. 1996. Stroke 27:709. (Block)
  4. Iguchi A, et al. 1997. Cell Struct. Funct. 22:357. (Block)
  5. Wyder L, et al. 2000. Cancer Res. 60:4682. (IHC)
  6. Wiewrodt R, et al. 2002. Blood 99:912. (IHC)
  7. McQualter JL, et al. 2009. Stem Cells. 27:623. (IHC) PubMed
  8. Chacko AM, et al. 2012. PLoS One 7:e34958.
  9. Greineder CF, et al. 2013. PLoS One. 14:80110. PubMed
Product Citations
  1. Barrett N, et al. 2016. Cell Rep. 16: 1039-1054. PubMed
  2. Smith NR, et al. 2017. Cell Mol Gastroenterol Hepatol. 0.395138889. PubMed
  3. García-Prat L, et al. 2020. Nat Cell Biol. 22:1307. PubMed
  4. Yagishita Y, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  5. Wagner G, et al. 2017. Sci Rep. 7:40881. PubMed
  6. Weeden C, et al. 2017. PLoS Biol. 10.1371/journal.pbio.2000731. PubMed
  7. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  8. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  9. Hu X, et al. 2016. Nat Commun. 7:13095. PubMed
  10. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  11. Fu X, et al. 2015. J Biol Chem. 290: 26445 - 26456. PubMed
  12. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  13. DellOrso S, et al. 2021. STAR Protocols. 2(2):100451. PubMed
  14. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  15. Minatoguchi S, et al. 2022. Sci Rep. 12:5389. PubMed
  16. Han YH, et al. 2021. Science. 373:. PubMed
  17. Campanario S, et al. 2021. Front Cell Dev Biol. 8:620409. PubMed
  18. Solanas G, et al. 2017. Cell. 170:678. PubMed
  19. Plein A, et al. 2018. Nature. 562:223. PubMed
  20. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  21. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  22. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  23. Duan L, et al. 2021. Immunity. 54:2256. PubMed
  24. Reddy A, et al. 2020. Cell. 183:62. PubMed
  25. Kumar B, et al. 2020. Haematologica. Online ahead of print:. PubMed
  26. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  27. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  28. Ni C, et al. 2022. Nat Commun. 13:5919. PubMed
  29. Pezoldt J, et al. 2022. Nat Commun. 13:7227. PubMed
  30. Gordon E, et al. 2010. Development. 137:3899. PubMed
  31. Berg AL, et al. 2022. Cancers (Basel). 14:. PubMed
  32. Zink J, et al. 2021. EMBO Rep. 22:e48961. PubMed
  33. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  34. Linnerbauer M, et al. 2022. JCI Insight. 7:. PubMed
  35. Su Y, et al. 2020. Cell Death Differ. 949:27. PubMed
  36. Merrell AJ, et al. 2021. Hepatology. 74:444. PubMed
  37. Ito K, et al. 2014. Proc Natl Acad Sci U S A. 111:3080. PubMed
  38. Cheng HW, et al. 2022. Nat Commun. 13:2027. PubMed
  39. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  40. Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed
  41. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  42. Schwörer S, et al. 2016. Nature. 540:428-432. PubMed
  43. Stock M, et al. 2015. Osteoarthritis Cartilage. 23: 1221-1225. PubMed
  44. El Agha E, et al. 2017. Cell Stem Cell. 1.014583333. PubMed
  45. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  46. Ben-Moshe S, et al. 2019. Nat Metab. 1:899. PubMed
  47. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  48. Lu Z, et al. 2021. J Clin Invest. 131:. PubMed
  49. Smith NR, et al. 2018. Cell Mol Gastroenterol Hepatol. 6:79. PubMed
  50. Geng Y, et al. 2022. Nat Commun. 13:7114. PubMed
  51. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
  52. Ognjenovic NB, et al. 2020. Dev Cell. 55:544. PubMed
  53. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  54. Zhuo X, et al. 2021. Biomed Rep. 15:64. PubMed
  55. Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed
  56. Yoldi G, et al. 2016. Cancer Res . 76: 5857 - 5869. PubMed
  57. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  58. Dong H, et al. 2022. Nat Metab. 4:90. PubMed
  59. Nakao M, et al. 2021. Sci Rep. 11:18384. PubMed
  60. Kimmel JC, et al. 2021. Cell Reports. 35(4):109046. PubMed
  61. Kabir AU, et al. 2018. JCI Insight. 3. PubMed
  62. Cui Y, et al. 2020. Eur J Pharmacol. 881:173233. PubMed
  63. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
RRID
AB_830756 (BioLegend Cat. No. 102417)
AB_830757 (BioLegend Cat. No. 102418)

Antigen Details

Structure
Ig superfamily, 130-140 kD
Distribution

Endothelial cells, platelets, granulocytes, monocytes/macrophages, dendritic cells, T and B cell subsets

Function
Adhesion
Ligand/Receptor
CD38, αV3 integrin
Cell Type
B cells, Dendritic cells, Endothelial cells, Granulocytes, Macrophages, Monocytes, Neutrophils, Platelets, T cells
Biology Area
Angiogenesis, Cell Adhesion, Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. DeLisser HM, et al. 1994. Immunol. Today 15:490.
3. Newman PJ, et al. 1990. Science 247:1219.

Gene ID
18613 View all products for this Gene ID
UniProt
View information about CD31 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 07.19.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account